Tag: Pharmaceutical industry

Merck (NYSE:MRK) recently reported its financial results for the second quarter of 2024, exceeding expectations and impressing both myself and Wall Street analysts. The...

GRI Bio, a biotechnology company based in La Jolla, California, has shared promising preclinical data on its potential treatment for Idiopathic Pulmonary Fibrosis (IPF)....

Mirum Pharmaceuticals, Inc. recently held an investor call to discuss the interim analysis results from two important studies involving the drug Volixibat. The Volixibat...

Alvotech and STADA have expanded their strategic alliance by partnering on AVT03, a biosimilar to Prolia® and Xgeva® (denosumab) for the treatment of osteoporosis...

Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024...

High Throughput Screening (HTS) Market Poised for Significant Growth, Technavio ReportsThe global high throughput screening (HTS) market is projected to experience substantial growth, with...